You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 10, October 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  State of the Art
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Somatic Gene Therapy

Methods for the Present and Future

Bert W. O'Malley, Jr, MD; Fred D. Ledley, MD

Arch Otolaryngol Head Neck Surg. 1993;119(10):1100-1107.


Abstract

Somatic gene therapy involves the introduction of novel genetic material into somatic cells to express therapeutic gene products. This emerging technology holds great promise for the treatment of both inherited and acquired diseases. This review summarizes the principles of gene therapy and approaches that are being investigated in experimental animals and clinical trials. These include the construction of recombinant viruses capable of carrying genes into cells by the process of infection as well as the use of DNA molecules that are capable of being used like conventional medicines. Some methods for gene therapy lead to permanent insertion of genes into targeted cells, while others are designed to express a therapeutic product with a defined half-life and duration of action. The goal is to establish site-specific and regulated expression of therapeutic products. The demonstrated safety and public acceptance of initial clinical trials will lead to widespread investigation of applications in both medicine and surgery in the near future.

(Arch Otolaryngol Head Neck Surg. 1993;119:1100-1107)



Author Affiliations

From the Departments of Otorhinolaryngology (Dr O'Malley), Cell Biology (Dr Ledley), and Pediatrics (Dr Ledley), Baylor College of Medicine, Houston, Tex.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human Insulinlike Growth Factor 1 Gene Transfer Into Paralyzed Rat Larynx: Single vs Multiple Injection
Shiotani et al.
Arch Otolaryngol Head Neck Surg 1999;125:555-560.
ABSTRACT | FULL TEXT  

IGF-1 Gene Transfer Into Denervated Rat Laryngeal Muscle
Flint et al.
Arch Otolaryngol Head Neck Surg 1999;125:274-279.
ABSTRACT | FULL TEXT  

Somatic Gene Therapy in Otolaryngology--Head and Neck Surgery
O'Malley and Ledley
Arch Otolaryngol Head Neck Surg 1993;119:1191-1197.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.